Many people report that belching provides temporary relief, only for the discomfort to return minutes later
Retatrutide seems to help with more weight loss than semaglutide
Ozempic was the first semaglutide drug, an GLP-1 (glucagon-like peptide 1) agonist and was approved to help improve blood sugar levels in patients with Type II diabetes in 2017
(Dry mouth, enamel erosion, nausea/vomiting, dietary changes, caries risk) MDPI Biology Journal
A JAMA study found GLP-1 agonists for weight loss raised risks of pancreatitis (9x), bowel obstruction (4x), and gastroparesis (3x) compared to other treatments
What the STEP 4 data makes clear is that weight regain is a real possibility after stopping the medication, which is why a long-term maintenance strategy matters